C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 120 filers reported holding C4 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $807,444 | -43.4% | 434,110 | -16.4% | 0.00% | 0.0% |
| Q2 2023 | $1,427,742 | +134.2% | 519,179 | +167.4% | 0.00% | 0.0% |
| Q1 2023 | $609,666 | +20.2% | 194,161 | +125.9% | 0.00% | 0.0% |
| Q4 2022 | $507,170 | -55.6% | 85,961 | -33.9% | 0.00% | 0.0% |
| Q3 2022 | $1,141,000 | +92.1% | 130,082 | +65.1% | 0.00% | 0.0% |
| Q2 2022 | $594,000 | -28.3% | 78,788 | +206.2% | 0.00% | 0.0% |
| Q4 2021 | $829,000 | +87.6% | 25,735 | +160.4% | 0.00% | – |
| Q3 2021 | $442,000 | -29.4% | 9,883 | -40.2% | 0.00% | -100.0% |
| Q2 2021 | $626,000 | +211.4% | 16,532 | +204.5% | 0.00% | – |
| Q1 2021 | $201,000 | -51.8% | 5,430 | -56.8% | 0.00% | – |
| Q4 2020 | $417,000 | – | 12,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
| Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
| Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
| Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
| Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
| Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
| P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
| RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |